Predicting ADC efficacy with PDO models and real-world dataPDO screening and RWD analysis identify a novel signature for ADC sensitivityINDICATIONUrinaryBIOMARKERNECTIN-4Related casesCharacterizing CLDN18.2 and HER2 expression in gastroesophageal cancerDeveloping a gene expression signature for first-line treatment in metastatic CRCHigh WRN expression and immunotherapy outcomes in MSI-H/dMMR colorectal cancer
